JOURNAL
Reflections on injection-layer selection
Reflections on injection-layer selection. Source observations, research context and limitations.
This article discusses the source author’s earlier literature, cases and experiences. Research populations and limitations matter; individual diagnosis and treatment require clinical assessment.
Why tissue layers matter
The source records a lecture emphasizing anatomy alongside product selection. Skin, superficial fat, SMAS, deep fat and periosteum have different relationships across facial sites, with different vessels, nerves and movement. A material’s response may depend on location and tissue condition.
Layers discussed in the lecture
The dermis contains fibroblasts, but local accumulation can also create irregularity, nodules or vascular problems. Subdermal, deep-fat and supraperiosteal sites have different functions and risks; none is universally ideal or safe.
The source distinguishes structural support from excessive filling. HA also has tissue effects and CaHA has initial volumizing effects, so “HA fills, CaHA regenerates” is too simple. Detailed depths, volumes and cannula directions were omitted from this patient-facing version.
Forehead and scalp discussion
The lecture considered the subgaleal space and tissue distribution. It does not establish that injection in a particular layer spreads naturally or is safe. Anatomy, product labeling and risks still require assessment. Proposed remodeling and clinical forehead or scalp outcomes are separate research questions.
The author describes the subgaleal region as influential in the development of a forehead–scalp research perspective. The source reports work on scalp blood flow, dermal thickness and tissue response and a poster presentation at a Merz Innovation Forum, with a Best Poster Award. The presentation, award and outcome details require verification and must not be treated as evidence of an approved hair-loss treatment.
The author reflects on the meaning of that research experience and describes using ultrasound in further work. A personal preference for a tissue plane is not a universal injection recommendation, and a conference award does not establish comparative efficacy or safety.
Materials linked by the source
Source: Original post on Dr. Hyemi Yu’s Naver blog (Korean)
The original publication date and the website revision date are shown separately.